publication date: Apr. 3, 2015

Over 48 Hours, Power Shifts at NCI, ACS, Dana-Farber and MD Anderson

Over the first two days in April, massive leadership changes occurred at top institutions in cancer research:

• On April 1, the top job at NCI switched from Harold Varmus to Douglas Lowy, with the Lowy being formally named acting director.

• On April 1, Edward Benz announced his plans to leave presidency at Dana-Farber Cancer Institute, and the institution’s board began the search for his successor.

• On April 2, the American Cancer Society announced that the job of CEO would go to former Johnson & Johnson executive Gary Reedy.

• On April 2, the UT System announced that Lynda Chin will be vacating her jobs as head of genomic medicine and scientific director of a research institute she co-founded. Chin, who is married to MD Anderson President Ronald DePinho, came to Houston from Dana-Farber as a team in 2011.

Now Chin will be moving to Austin to assist the UT System’s new chancellor. Not only has she been DePinho’s key collaborator, but the controversies at MD Anderson went public as a result of an effort by the cancer center to obtain $18 million in state funding for Chin’s institute.

In another development, the Houston Chronicle published an editorial that draws parallels between managing cancer and managing a cancer center. “The chancellor and the board of regents should treat this management problem with the same urgency as physicians do when treating their patients,” the editorial urged.

 

Lowy Pledges to be an “Active” Acting … Continue reading 41-13 Over 48 Hours, Power Shifts at NCI, ACS, Dana-Farber and MD Anderson

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.